The number of samples was 11 of EGFR mutation-positive lung cancer, 19 of EGFR mutation-negative lung cancer, 11 of leucocyte DNA from normal individuals and 7 of cfDNA from normal individuals. The gene discussed is EGFR; the disease is lung carcinoma.